Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma.
Analysis of Follicle-Stimulating Hormone Receptor in Infantile Hemangioma.
复制标题
DOI:
10.1097/sap.0000000000001438
复制
发表时间:
2018-04
影响因子:
1.5
通讯作者:
Greene AK
中科院分区:
文献类型:
--
作者:
Maclellan RA;Konczyk DJ;Goss JA;Greene AK
The life-cycle of infantile hemangioma (IH) and secretion of follicle-stimulating hormone (FSH) are identical. We previously have shown that IH contains the receptor for follicle-stimulating hormone (FSHR). The purpose of this study was to identify which cell type(s) in IH expresses FSHR. Human proliferating IH tissues obtained during a clinically-indicated surgical procedure were used. Paraffin sections and isolated cell populations (endothelial, pericyte, stem cell) were subjected to immunofluorescence for FSHR. Tissues were co-stained with DAPI, anti-α smooth muscle actin, or biotinylated ULEX Europaeus Agglutinin I to identify nuclei, pericytes, and endothelial cells, respectively. Whole tissue and purified single cell populations underwent PCR for FSHR. Positive control specimens (ovary, sertoli cells) and negative control tissues (skin/subcutis, hepatic cells) were included. Immunofluorescence of 9 IHs demonstrated that FSHR was enriched in pericytes compared to endothelial cells. FSHR was expressed in 6 of 6 whole tissue IHs along with the positive control via PCR. FSHR was not present in the negative control samples. Four of 5 sets of pericytes expressed FSHR by PCR. Neither IH endothelial cells, IH stem cells, or negative control cells exhibited FSHR by PCR. Because the secretion of FSH correlates with the growth pattern of IH, FSH might be involved in the disease process. FSHR is enriched in the pericytes of IH suggesting that this cell type may be involved in the pathogenesis of the tumor.